SLC5A2 and diabetes mellitus: Thus, taken together with previous work, we suggest that early, sufficient, and stable blood glucose lowering, possibly with multiple agents, including higher- and/or multiple daily-dosing of SGLT2 inhibition in combination with RAS blockade, may be required to achieve maximal renoprotection in diabetes.